Therapeutic Plasma Exchange (TPE) for Long COVID
A Cellular Approach to Persistent Post-Viral Symptoms
For many individuals, COVID-19 does not fully resolve after the initial infection. Weeks to months later, symptoms such as fatigue, brain fog, shortness of breath, pain, and exercise intolerance may persist — a condition now commonly referred to as Long COVID or Post-Acute Sequelae of SARS-CoV-2 Infection (PASC).
At Aether Medicine, we approach Long COVID as a problem of immune dysregulation, chronic inflammation, and impaired cellular signaling. One emerging therapy that addresses these drivers at their source is Therapeutic Plasma Exchange (TPE).
Why Long COVID Persists
Long COVID is not a single disease, but rather a complex, multi-system condition. Research suggests several overlapping mechanisms may contribute to ongoing symptoms, including:
• Persistent inflammatory proteins and cytokines
• Abnormal immune activation or autoantibody formation
• Endothelial and microvascular dysfunction
• Altered coagulation and fibrin deposition
• Mitochondrial and metabolic dysfunction
• Autonomic nervous system imbalance
These processes can remain active long after the virus itself has cleared, creating a prolonged state of physiologic stress and impaired recovery.
The Role of Plasma in Long COVID
Plasma is the liquid component of blood that carries immune proteins, inflammatory mediators, antibodies, clotting factors, and metabolic byproducts. In Long COVID, plasma may contain elevated levels of substances that perpetuate inflammation and immune dysfunction.
When these circulating factors remain present, they can continue to disrupt normal cellular communication, tissue repair, and energy production.
How Therapeutic Plasma Exchange Works
Therapeutic Plasma Exchange is a medical procedure that removes a portion of a patient’s plasma and replaces it with a clean replacement solution, typically albumin.
During TPE:
Blood is gently circulated through a specialized medical device
Plasma is separated from blood cells
Plasma containing inflammatory and immune-active substances is removed
Clean replacement fluid is combined with the patient’s blood cells
Filtered blood is returned to the body
The goal is to reduce the circulating inflammatory burden and allow the immune system to reset toward a more regulated state.
Why TPE May Help in Long COVID
TPE does not target the virus itself. Instead, it addresses the downstream consequences of infection that may be keeping patients symptomatic.
Potential benefits in Long COVID may include:
• Reduction of inflammatory cytokines
• Removal of pathogenic autoantibodies
• Improved endothelial and microvascular function
• Reduced immune overactivation
• Improved oxygen delivery and cellular metabolism
• Support for neurologic and cognitive recovery
By improving the internal environment, TPE may allow the body’s natural repair mechanisms to function more effectively.
Who May Be a Candidate for TPE in Long COVID
TPE may be considered for individuals who:
• Have persistent symptoms months after COVID-19 infection
• Experience significant fatigue, brain fog, or exercise intolerance
• Have not responded to conventional supportive therapies
• Show laboratory evidence of ongoing inflammation or immune dysregulation
At Aether Medicine, every patient undergoes a comprehensive evaluation to determine whether TPE is appropriate as part of a broader treatment strategy.
TPE as Part of an Integrated Recovery Plan
At Aether Medicine, TPE is not used in isolation. Long COVID recovery often requires a multi-layered approach that may include:
• Advanced laboratory and biomarker assessment
• Metabolic and mitochondrial support
• Hormone optimization when indicated
• Nutritional and gut health interventions
• Autonomic and stress physiology regulation
• Peptides and targeted cellular therapies
This integrative model allows treatment to be personalized and outcomes to be measured over time.
Safety and Experience
Therapeutic Plasma Exchange has been used safely in hospital settings for decades. When performed in an appropriate clinical environment with trained medical staff, it is generally well tolerated.
At Aether Medicine, TPE is delivered using hospital-grade equipment in a private, concierge setting with continuous monitoring and strict safety protocols.
Why Patients Are Seeking Advanced Options for Long COVID
Many individuals with Long COVID feel unheard or dismissed after standard evaluations fail to explain ongoing symptoms. TPE represents a shift toward addressing the biologic drivers of persistent illness rather than treating symptoms alone.
As research continues to evolve, therapies that directly reduce inflammatory and immune-active circulating factors may play an increasingly important role in post-viral recovery.
Therapeutic Plasma Exchange for Long COVID at Aether Medicine
Aether Medicine is launching its Therapeutic Plasma Exchange program in January 2026, bringing advanced plasma exchange therapy to the Philadelphia Main Line.
The program is led by Dr. Asare B. Christian, a Harvard- and Johns Hopkins-trained physician with expertise in integrative medicine, metabolic health, pain management, and longevity science.
Next Steps
If you are struggling with lingering symptoms after COVID-19 and are seeking a more comprehensive, root-cause approach, a consultation can help determine whether Therapeutic Plasma Exchange may be appropriate for you.
Call: 484-806-1101
Visit: www.aethermedicine.com
At Aether Medicine, we focus on cellular health to support recovery, resilience, and long-term healthspan — because healing after Long COVID requires more than symptom management.